FDA Approves First Drug to Treat Severe Multiple Sclerosis – New York Times


New York Times

FDA Approves First Drug to Treat Severe Multiple Sclerosis
New York Times
Jerrie Gullick, 51, was part of the clinical trial for Ocrevus and said the drug had significantly slowed the progression of her primary progressive multiple sclerosis. Credit Sam Hodgson for The New York Times. The Food and Drug Administration
New MS Drug Ocrevus Wins FDA ApprovalNBCNews.com
FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and Primary Progressive FormsMultiple Sclerosis News Today
Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp BiogenTheStreet.com
UCSF News Services –Business Wire (press release) –Reuters –FiercePharma
all 15 news articles »

View original article
Author:

Powered by WPeMatico